Pham, Tuan – Trademark Portfolio
Entity Type: 01
Pham, Tuan has 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include ANSA and ATHOME. The portfolio includes 4 registered trademarks. Filings span 5 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 10 (Medical Apparatus). This trademark owner is based in San Diego, CA.
15175 Innovation Drive
15175 Innovation Drive
San Diego, CA 92128
Showing of trademarks Trademarks
Trademark Classifications
Pham, Tuan's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Pham, Tuan have?
Pham, Tuan has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 4 abandoned, 3 cancelled.
What trademark classes does Pham, Tuan file in?
Pham, Tuan files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Pham, Tuan's most well-known trademarks?
Pham, Tuan's registered trademark portfolio includes well-known marks such as ANSA and ATHOME. These are among 4 currently registered trademarks in the portfolio.
What is Pham, Tuan's trademark registration success rate?
Pham, Tuan has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.